Peripheral neuropathy and ototoxicity of dichlorodiamineplatinum: Instrumental evaluation

Cis-diamminedichloroplatinum (II)

1977 • 424 citations

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies

1984 • 401 citations

Peripheral sensory neuropathy and cisplatin chemotherapy

1984 • 368 citations

The significance of the "dying back" process in experimental and human neurological disease.

1964 • 313 citations

Neurotoxicity of antineoplastic drugs.

1982 • 231 citations

Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)

1972 • 168 citations

Ototoxicity of cis-diamminedichloroplatinum (II): Influence of dose, schedule and mode of administration

1983 • 139 citations

Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig

1975 • 138 citations

Neurotoxicity of chemotherapeutic agents after blood‐brain barrier modification: Neuropathological studies

1983 • 129 citations

Peripheral neuropathy following a single exposure to arsenic

1977 • 114 citations

Changes in the stria vascularis of the guinea pig due to cis-platinum

1984 • 95 citations

Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment

1979 • 71 citations

Acute nephrotoxicity following cis-dichlorodiammine-platinum

1982 • 70 citations

Ophthalmologic toxicity after cis-dichlorodiammineplatinum(II) therapy.

1978 • 65 citations

The Effects of Thallium Salts, with Particular Reference to the Nervous System Changes<subtitle>A REPORT OF THREE CASES</subtitle>

1974 • 64 citations

cis-Platinum-induced hypomagnesemia and peripheral neuropathy

1983 • 50 citations

Neurotoxicity of cis-platinum: Pathology of the central and peripheral nervous systems

1980 • 32 citations

Audiometric monitoring of cis-platinum ototoxicity

1983 • 29 citations

Gastrointestinal toxicity of cis-diamminedichloroplatinum (II).

1982 • 27 citations

Sensory neuropathy in cis-platinum chemotherapy

1980 • 20 citations

Deleted Work

1955 • 0 citations